Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2026)

Inspire Medical Systems' Cost of Revenue history runs 10 years deep, the most recent figure standing at $27.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 9.89% year-over-year to $27.7 million; the TTM figure through Mar 2026 stood at $130.2 million (up 0.97% YoY), while the FY2025 annual figure was $133.2 million, up 8.33% from the prior year.
• Cost of Revenue came in at $27.7 million for Q1 2026 at Inspire Medical Systems, down from $36.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $36.1 million in Q4 2025 to a low of $10.0 million in Q1 2022.
• A 5-year average of $26.3 million and a median of $27.7 million in 2026 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue surged 129.43% in 2022 and fell 9.89% in 2026, its largest moves.
• Inspire Medical Systems' Cost of Revenue stood at $22.2 million in 2022, then gained by 26.64% to $28.1 million in 2023, then advanced by 28.28% to $36.0 million in 2024, then advanced by 0.23% to $36.1 million in 2025, then decreased by 23.29% to $27.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $27.7 million, $36.1 million, and $31.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison